Search This Blog

Wednesday, May 6, 2020

Ultragenyx Pharmaceutical EPS misses by $0.37, misses on revenue

Ultragenyx Pharmaceutical (NASDAQ:RARE): Q1 GAAP EPS of -$2.05 misses by $0.37.
Revenue of $36.31M (+99.8% Y/Y) misses by $0.43M.
Press Release
https://seekingalpha.com/news/3570401-ultragenyx-pharmaceutical-eps-misses-0_37-misses-on-revenue
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)